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ABSTRACT
Zingiber zerumbet has been traditionally used as an anti-inflammation and antioxidant agent. The present study 
investigates the neuroprotective effects of ethyl acetate extract of Z. zerumbet against oxidative stress on paraquat 
(PQ)-induced Parkinsonism in rats. Forty male Sprague-Dawley rats were divided into five groups: Negative control 
(normal saline), positive control (N-acetylcysteine, NAC 20 mg/kg + PQ 10 mg/kg), PQ only, 200 mg/kg Z. zerumbet + 
PQ and 400 mg/kg Z. zerumbet + PQ. The extract was given orally for 19 consecutive days and PQ was administered 
intraperitoneally on day 8-12th of the treatment regime. Both serum and fresh brains containing substantia nigra (SN) 
region were taken for biochemical and histological analysis. Administration of both 200 and 400 mg/kg ethyl acetate 
Z. zerumbet extracts to the PQ-treated groups have resulted in: Decreased levels of MDA and PC in the SN homogenates; 
and increased SOD, GPx; and CAT activities in the SN and serum. Overall, ethyl acetate extract of Z. zerumbet reduced 
oxidative stress in the SN of PQ-induced neuronal damages, therefore, has the potential to be developed as a preventive 
agent for neurodegenerative disorders caused by environmental toxins.
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ABSTRAK
Zingiber zerumbet telah digunakan secara tradisi sebagai agen anti-keradangan dan antioksidan. Kajian ini dijalankan 
untuk mengkaji kesan  neurolindungi ekstrak etil asetat Z. zerumbet terhadap tekanan oksidatif dalam tikus Parkinsonisme 
aruhan parakuat (PQ). Empat puluh tikus Sprague-Dawley jantan dibahagikan kepada lima kumpulan: Kawalan negatif 
(salin normal), kawalan positif (N-asetilcysteine, NAC 20 mg/kg + PQ 10 mg/kg), PQ sahaja, 200 mg/kg Z. zerumbet 
+ PQ dan 400 mg/kg Z. zerumbet + PQ. Ekstrak diberikan secara oral gavaj selama 19 hari berturut-turut dan PQ 
diberikan secara intraperitoneal pada hari ke-8 sehingga ke-12 rejim rawatan. Kedua-dua sampel serum dan tisu otak 
pada bahagian substantia nigra (SN) diambil untuk analisis biokimia dan histologi. Pemberian ekstrak etil asetat Z. 
zerumbet pada kedua-dua dos 200 dan 400 mg/kg kepada kumpulan yang dirawat PQ telah: Menurunkan tahap MDA 
dan PC dalam homogenat SN; meningkatkan aktiviti SOD, GPx, dan CAT dalam SN dan serum; serta meningkatkan aras 
glutation terturun (GSH) dalam SN. Secara keseluruhannya, ekstrak etil asetat Z. zerumbet didapati dapat mengurangkan 
tekanan oksidatif pada kawasan SN di otak tikus yang diaruh kerosakan neuron oleh PQ. Seterusnya, berpotensi untuk 
dibangunkan sebagai agen pencegah gangguan penyakit neurodegeneratif yang disebabkan oleh pendedahan terhadap 
toksin dari alam sekitar.
Kata kunci: Antioksidan; parakuat; penyakit Parkinson; tekanan oksidatif; Zingiber zerumbet
INTRODUCTION
Parkinson’s disease (PD) is the second most common 
neurodegenerative disorder after Alzheimer’s disease 
(Yokohama et al. 2008). Parkinson’s disease exerts an 
enormous impact on the lives of affected individual, their 
families and also the society (Giasson et al. 2002). Meta-
analysis of 27 international studies showed that PD affects 
both gender, with increasing number of incidence as age 
advances. Though the number is higher in males at all age 
groups, further analysis showed that the incidence affecting 
the males is significantly higher in the 60-69 and 70-79 age 
groups compared to the women of the same age groups 
(Hirsch et al. 2016). 
 PD is the result of selective loss of dopaminergic 
neurons in the substantia nigra pars compacta (SNpc) 
(McCollum et al. 2010). It also involves an abnormal 
deposition of intracellular inclusions or Lewy bodies 
within the brain (Lewis & Cookson 2012). Lewy bodies 
are protein aggregates composed mainly of α-synuclein and 
ubiquitin (Blesa et al. 2012). Effects from the loss of striatal 
dopamine and dysfunction of the nigrostriatal pathway 
resulted in a group of motor symptoms such as rigidity, 
tremor, bradykinesia and postural imbalance (Seet et al. 
2010). Although the pathogenesis of this disease is still 
unclear, it is considered to be potentiated by the interaction 
between two factors; environment and genetic (Shafique et 
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al. 2011). It is well known that exposure to environmental 
herbicides is one of the environmental factors that have 
been reported to contribute to the pathogenesis of PD 
(Shafique et al. 2011). However, the risk of PD in human 
is reported to be higher in those with paraquat exposure 
and having the defective gene that encodes glutathione 
S-transferase T1 (GSTT1)(Goldman et al. 2012).
 Paraquat (1, 1 ‘dimethyl-4, 4’-bipyridinium) is among 
the most commonly used herbicides in the agricultural 
sector worldwide (Cha et al. 2014). Paraquat (PQ) is a 
highly toxic quaternary ammonium herbicide that has been 
shown to produce toxicity particularly in the dopaminergic 
neurons of the rat and mouse brains (Blanco-Ayala et al. 
2014; Yang & Tiffany-Castiglioni 2005). PQ is structurally 
similar to 1-methyl-4-phenylpyridinium ion (MPP+), a 
known neurotoxic and the active metabolite of 1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine or MPTP (Brooks et 
al. 1999). Both PQ and MPTP ultimately cause the loss of 
dopaminergic neurons in the SN that leads to the clinical 
symptoms of Parkinsonism (Wesseling et al. 2001). PQ is 
considered as a potent oxidative stress inducer (Lascano 
et al. 2012). Oxidative stress plays a major role in the 
pathogenesis of Parkinson’s disease through the induction 
of nigral dopaminergic neuronal cells death (Nikolova et 
al. 2012). The death of these neuronal populations by PQ 
is mainly attributed to impaired mitochondrial functions 
as well as increased production of reactive oxygen species 
and reduction in oxygen consumption (Blanco-Ayala 
et al. 2014; Huang et al. 2016). PQ specific toxicity to 
dopaminergic neurons via oxidative stress mechanism 
in rats has prompted the current study to utilize the 
PQ-induced Parkinsonism model in order to study the 
antioxidant strategies of a herbal plant namely Zingiber 
zerumbet against Parkinsonism.
 Herbal medicine has gain lots of attention due to the 
presence of various natural compounds that are beneficial 
to health including alleviating pathological symptoms. 
Zingiberaceae belong to order of Zingiberales, which 
forms an isolated group among the monocotyledons. 
Approximately 1000 species of Zingiberaceae are found in 
tropical Asia. In Peninsular Malaysia there are more than 
160 species of Zingiberaceae identified (Abdul et al. 2008). 
Only a small portion of these ginger species have been 
cultivated for its use as vegetables, condiments, spices, 
flavors, dyes, medicines as well as ornaments (Habsah et 
al. 2000).
 Zingiber zerumbet has been claimed to have high 
medicinal values (Yob et al. 2011). Zingiber zerumbet or 
locally known as lempoyang is used in local traditional 
medicine as a remedy for swelling, sores and loss of 
appetite (Abdul et al. 2008). The rhizome of Z. zerumbet 
has been used for anti-inflammation, anti-ulceration, 
antioxidant, anti-pyretic, analgesic and anti-microbe 
(Somchit et al. 2005). This rhizome is reported to contain 
alkaloid, saponin, flavonoids and polyphenol as well as 
the volatile oil (Batubara 2013). The volatile oil of Z. 
zerumbet contains zerumbone as its main active constituent 
(Bhuiyan et al. 2009). Among the differences in the 
extraction methods employed, ethyl acetate extraction 
gives the highest yield of zerumbone (51.57%) (Budin et al. 
2013). Zerumbone has versatile pharmaceutical properties 
including anti-inflammatory, antitumor, antioxidant, 
antimicrobial and antinociceptive activities (Somchit et 
al. 2012). Zerumbone has also been reported to inhibit 
proliferation of leukemic, cervical, ovarian, colon, breast 
and liver cancers (Abdelwahab et al. 2012, 2011). 
 As a neuroprotective agent, an administered substance 
of interest should be able to reverse some of the pathological 
damage or prevent further damage to the neuronal cells. 
A lot of study has found that active compounds present in 
the natural products have high contents of antioxidant and 
anti-inflammatory properties. These properties can protect 
the neurons against neurodegenerative conditions thereby 
preserving or even enhancing cognitive function (Essa et 
al. 2012; Hamid et al. 2018). Z. zerumbet extracts and the 
pure compound, Zerumbone, fit the ideal characteristics 
of a neuroprotective drug due to their anti-inflammatory, 
antioxidant and antiplatelet aggregate activities as 
reviewed in Yob et al. (2011). 
 In the current study, the main aim is to investigate 
the neuroprotective potential of ethyl acetate extract of 
Z. zerumbet rhizome through its antioxidants activities in 
paraquat-induced Parkinsonism in rats. The effects were 
determined by measuring the levels of oxidative stress 
markers (malondialdehyde (MDA), protein carbonylation), 
endogenous antioxidants (GSH, superoxide dismutase 
(SOD), catalase), histological changes of the neurons in 
the SN and behavioral analysis. 
MATERIALS AND METHODS
PLANT MATERIALS
Fresh rhizomes of Z. zerumbet were collected from 
Temerloh, Pahang. The specimen was first validated and 
kept in the Herbarium, Faculty of Science and Technology 
(FST), Universiti Kebangsaan Malaysia (voucher number is 
UKMB-29952). The rhizomes were scrubbed and cleaned, 
chopped finely using dry blender and then air-dried at room 
temperature for three days. 
PLANT EXTRACTION
The air-dried chopped rhizomes were soaked at room 
temperature in 100% n-hexane. After 72 h, the hexane 
containing the chopped rhizomes was filtered, the resulting 
filtrate (hexane) was kept for the next stage and the rhizome 
residue was soaked again for 72 h with a fresh hexane. 
This cycle was repeated 3 times. The rhizome residue 
from the third cycle of hexane was soaked with another 
solvent, 100% fresh ethyl acetate and later with 100% 
methanol, following the same exact procedure as hexane. 
The resultant solvent extracts (filtrates) collected at each 
stage were evaporated using rotavapor apparatus to yield 
dried crude extracts of hexane, ethyl acetate and methanol. 
All the crude extracts were stored at 4°C until further use. 
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Prior to use, the Z. zerumbet ethyl acetate extract was 
dissolved in 100% dimethyl sulfoxide (DMSO) and diluted 
in phosphate buffered saline (PBS; pH7.4), aliquoted and 
kept as stock at -20°C. 
EXPERIMENTAL PROTOCOL
The procedures involving the use of laboratory animals 
were approved by the UKM Animal Ethical Committee 
(UKMAEC) with the following approval code reference: 
FSK/BIOMED/2013/ASMAH/14-NOV.15566-NOV.-2013-
JUNE-2014. Forty male Sprague-Dawley rats aged 
6-8 weeks (140-200 g) were purchased from the UKM 
Laboratory Animal Resource Unit. The animals were 
housed in a controlled environment with room temperature 
at 24°C ± 1 and a 12-h light/dark cycle. Food and water 
were provided ad libitum. Rats were randomly divided 
into five groups with n=7/group. The groups were negative 
control group (normal saline), NAC (N-acetylcysteine) + 
PQ (20 mg/kg of NAC with PQ), PQ (PQ treated-group), 
200 + PQ (200 mg/kg Z. zerumbet with PQ) and 400 + PQ 
(400 mg/kg of Z. zerumbet with PQ). Ethyl acetate extract 
of Z. zerumbet was given orally for 19 consecutive days 
and PQ was administered intraperitoneally (10 mg/kg) on 
Day 8-12 of the treatment regime. Both serum and fresh 
brains containing the SN region were taken for biochemical 
and histological analysis. Research timeline is shown in 
Figure 1. 
EXPERIMENTAL TIMELINE
Zingiber zerumbet extract was given to the respective 
groups for 19 days consecutively via oral gavage (Day-1 
- Day-19) (Figure 1). Respective groups of animals were 
injected intraperitoneally with paraquat daily from Day-
8 until Day-12 of the treatment regime and behavioural 
changes were observed. On Day-20, rats from all groups 
were killed and sampling was done. Both fresh brains 
containing SN and serum were taken for further analysis. 
SAMPLE PREPARATION
For the Z. zerumbet treatment group, the animals were 
killed 24 h after the last dose of Z. zerumbet extract on 
Day-19. Regardless of treatment, all animals were killed 
on Day-20. Prior to killing, the animals were anesthetized 
with KTX (Ketamine, xylazine and zoletil) with dosage 
of 0.5 mL/kg (Hamid et al. 2018) and decapitated to 
collect trunk blood and brains for sampling. Blood 
was collected in plain tubes and allowed to coagulate 
at room temperature for 3 h. Serum was obtained after 
centrifugation at 3000 rpm for 10 min and stored at -20°C 
until further use. The SN area was identified and isolated 
using brain matrices (Tedpella, USA) and washed with 
iced-cold KCl to wash off traces of blood. For histological 
purposes, the brain slice containing SN was fixed in 10% 
formalin, while for biochemical analysis; the SN was 
minced into small pieces, weighed and homogenized 
with 1:15% KCl solution at a ratio of 3 mL/g (v/w). The 
brain homogenate was then centrifuged at 4000 rpm for 
20 min at 4°C. The supernatant obtained was then stored 
at -20°C until further analysis.
BEHAVIORAL OBSERVATION
Tremor   Tremor is one of the clinical hallmarks of PD. This 
behavioral study was performed to verify the Parkinsonism 
symptoms which were manifested in the PQ-induced rats. 
The phasic tremor of the whole body was evaluated and 
scored according to Coward et al. (1977); 0, no tremor; 1, 
occasional isolated twitches; 2, moderate or intermittent 
tremor associated with short periods of calmness; and 3, 
pronounced continuous tremor.
BIOCHEMICAL ANALYSIS
Total Protein   Total protein determination was based on 
Bradford (1976) method. Standard curve was prepared 
from a 500 μg/mL of bovine serum albumin (BSA) by 
pipetting 0.2, 0.4, 0.6, 0.8 and 1.0 mL of the solution into 
glass tube. The concentration of the measured proteins 
was plotted against the corresponding absorbance resulting 
in a standard curve which was used to determine the 
protein concentration in the samples. Depending on the 
concentration, diluted serum and SN supernatant were 
pipetted into test tubes separately. The volume was adjusted 
to 0.1 mL with PBS. A total of 5 mL of protein reagent was 
added to the test tubes and the contents were mixed by mild 
vortexing. The measurement of the absorbance was done 
at 595 nm against a reagent blank prepared from 0.1 mL 
of the appropriate buffer and 5 mL of protein reagent. The 
readings were taken between 2 min to 1 h. 
FIGURE 1. The experimental timeline. Zingiber zerumbet extract was given for 19 days consecutively via oral gavage. Then, on Day-8 
until Day-12, the paraquat was injected daily (i.p) and the behavioural changes were observed. On Day-20, all the rats were sacrificed 
and sampling was done. Both fresh brains containing SN and serum were taken for further biochemical and histological analysis
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Malondialdehyde (MDA) Level   The formation of 
thiobarbituric acid reactive substances (TBARS), which 
are the byproduct of lipid peroxidation, was measured 
according to the method by Ledwozyw et al. (1986). In this 
assay, the presence of reactive aldehyde such as MDA (end 
product of lipid peroxidation) reacts with thiobarbituric 
acid (TBA) reagent under an acidic condition to generate a 
pink coloured product. A total of 0.1 mL of SN homogenate 
supernatant was added to 0.4 mL of distilled water. The 
mixture was then added with 2.5 mL of trichloroacetic 
acid (TCA) and left to incubate at room temperature for 
15 min. Then 1.5 mL of TBA was added and the resultant 
mixture was heated in a water bath at 100°C for 30 min 
or until a faint pink coloured solution was obtained. After 
cooling, the coloured product was added with 1 mL of 
butanol, vortexed for 3 min and the top layer of the resulting 
mixture was taken and the absorbance was measured using 
spectrophotometer at 532 nm. 
Protein Oxidation Level (Protein Carbonyl, (PC))   Protein 
oxidation was evaluated by the determination of protein 
carbonyl level. Dinitrophenylhydrazine (DPNH) reacts 
with protein carbonyl groups to produce the stable 2, 
4-dinitrophenyl (DNP) hydrazine protein adducts that can 
be detected spectrophotometrically at 370 nm according 
to the method by Levine et al. (1990). In short, proteins 
were precipitated by the addition of 20% TCA and were 
dissolved in (how much of DPNH). The results were reported 
as nmol/mg protein. 
Superoxide Dismutase (SOD) Activity   Superoxide 
dismutase activity was measured according to the method 
of Beyer and Fridovich (1987). In summary, the reaction 
mixture consisting of 50 mM potassium phosphate buffer 
pH7.8, 0.1 mM EDTA, 9.9 mM L-methionine, 5.7 × 10-5 nitro 
blue tetrazolium (NBT) and 2.5 × 10-2 % (w/v) Triton X-100 
and riboflavin (0.01 mL of 4.4%) were freshly prepared on 
the day of the assaying. A total of 1.0 mL of the reaction 
mixture was added to 20 μL of SN homogenate in a cuvette 
to initiate the reaction which was then placed in a box 
illuminated with 20 W neon lamps for 7 min. The reduction 
of NBT was measured at 560 nm spectrophotometrically. 
The results were calculated by subtracting the changes in 
absorbance of the blank from the sample and dividing Δ A 
by 0.012 to obtain the McCord-Fridovich units of activity.
Catalase (CAT) Activity   Catalase activity was determined 
as described by Aebi (1984). A total of 50 mM phosphate 
buffer (pH7.0) and 30% H2O2 were freshly prepared on 
the day of the assaying. Two mL of sample solution was 
mixed with 1 mL of H2O2. The decomposition of H2O2 
was measured at 240 nm via spectrophotometer using a 
blank containing 2 mL of the sample solution and 1 mL 
of phosphate buffer. The reaction time was ensured to be 
within 30 s.
Glutathione Peroxidase (GPx) Activity   Glutathione 
peroxidase measurement was determined at 340 nm 
spectrophotometrically using the method of Paglia and 
Valentine (1967). Both the blank and the system cuvettes 
contained 0.1 M KPO4 buffer (pH7.0), 2 μM EDTA, 10 
units/mL glutathione reductase, 4 mM sodium azide, 200 
mM NADPH and sample. In addition, the system cuvette 
contained 1.0 mM glutathione, GSH. After 10 min of pre-
incubation at 37°C, the reaction was started by adding 1.0 
mM H2O2 to the blank and system cuvettes. In order to 
correct the non-enzymatic oxidation of GSH and NADPH 
by H2O2, an additional blank assay in which the buffer was 
substituted for the sample was performed.
Glutathione (GSH) Level   The assay of GSH with DTNB was 
performed by following Ellman’s method (1959). Equal 
volume of 20% trichloroacetic acid (TCA) containing 1 
mM EDTA was added to the brain homogenate to precipitate 
the tissue protein. After 5 min, the resulting mixture was 
centrifuged for 10 min at 200 rpm. A total of 200 μL of 
the supernatant was transferred to a new set of test tubes 
and added with 1.8 mL of the Ellman’s reagent, 5, 5’dithio 
bis 2nitrobenzoic acid (DTNB). The resulting solution was 
measured at 415 nm against a blank. Absorbance values 
were compared with a standard curve generated. The GSH 
level was measured in nmol/mg protein. 
HISTOLOGICAL ANALYSIS
Histological examination on the region of interest of the 
brain was performed according to routine histological 
techniques. Briefly, after the animal was killed, the brain 
containing the SN region was isolated and harvested, 
rinsed in normal saline and sectioned into small pieces. 
The sectioned tissues were then fixed in 10% formalin, 
dehydrated in stepwise increasing concentration of ethanol 
solution (50% to 100%) and later embedded in paraffin. 
Tissue sections of 5 μm thickness were produced using 
microtome and fixed overnight on slides. The slides were 
subsequently stained with hematoxylin and eosin (H&E) 
and then analyzed under a light microscope (Motic Images, 
Hong Kong). 
STATISTICAL ANALYSIS
Statistical analysis was done using SPSS version 20.0 (IBM 
Corp., AS). Data was first analyzed using Shapiro-Wilk 
normality test. Later, one way analysis of variance (ANOVA) 
was employed to compare means between groups followed 
by posthoc Tukey test. Mixed ANOVA was used to analyze 
the differences in the tremor score. Data was expressed as 
means ± standard error of mean (SEM) with p<0.05 was 
considered as statistical significance.
RESULTS
TREMOR OBSERVATION
Tremors observed in the rats were evaluated and scored. 
In short, a score of 0 means absence of tremor, 1 indicates 
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occasional isolated twitches being observed, 2 indicates 
moderate or intermittent tremor associated with short 
periods of calmness, whereas a score of 3 indicates that the 
rats showed pronounced continuous tremor. Higher score 
indicates the severity of the symptoms shown (Figure 2). 
There was a noted decline in the tremor score for both 200 
and 400 mg/kg extract group compared to the PQ-treated 
group as seen in the post-induction period. Administration 
of Z. zerumbet in both the extract groups alleviated the 
severity of the tremors caused by PQ induction.
EFFECTS OF Z. ZERUMBET EXTRACT ON OXIDATIVE        
STRESS MARKERS
Administration of PQ for five consecutive days induced 
oxidative stress in the SN area as indicated by a significant 
increase in the level of protein carbonyl (Figure 3(B)). 
Induction of PQ in the Z. zerumbet treatment groups of 
both 200 + PQ and 400 + PQ showed significantly reduced 
levels of MDA and protein carbonyl when compared to the 
PQ-treated group (p<0.05). 
EFFECTS OF Z. ZERUMBET EXTRACT ON                 
ANTIOXIDANT STATUS
Administrations of PQ for five consecutive days also 
caused a significant reduction in the activities of CAT 
(Figure 3(D)) and GPx (Figure 3(E)) in the SN. In contrast, 
administration with either 200 or 400 mg/kg of Z. zerumbet 
extract significantly prevented the decreased in the enzyme 
levels and improved the activities of SOD (Figure 3(C)), 
CAT (Figure 3(D)) and GPx (Figure 3(E)) (p<0.05). In the 
serum, paraquat induction caused a significant reduction of 
SOD (Figure 4(A)) and CAT (Figure 4(B)) enzyme activities 
compared to the normal control group (p<0.05). However, 
administration of Z. zerumbet at 400 mg/kg increased both 
of these enzyme activities significantly when compared to 
the PQ-treated group (p<0.05).
HISTOLOGICAL OBSERVATION
Histological sections of the brain sample containing 
the SN region was scrutinized under a light microscope. 
There was presence of fibrillary aggregates called Lewy 
bodies (LBs) in the SN of the PQ-treated group (Figure 
4(D)). In our observation, administration of PQ caused 
the formation of fragmentation in the nucleus of the 
neurons and the presence of Lewy bodies. In contrast, 
administration of Z. zerumbet extract prevented the 
nucleus from undergoing fragmentation and thus 
appeared intact and normal (Figure 4(E)). 
DISCUSSION
In PD, there is growing evidence that oxidative stress 
mechanism play a role in causing neuronal cell death. 
In this study, administration of 10 mg/kg of PQ for five 
consecutive days was able to induce Parkinsonism in 
rats as demonstrated by behavioral observation (tremor). 
Co-administration of ethyl acetate extract of Z. zerumbet 
with PQ showed that there was a reduction in the oxidative 
stress level in Parkinsonism rats compared to the group 
that was given only PQ. Furthermore, the protective effect 
of Z. zerumbet was found to be more remarkable in the 
400 + PQ group than in the 200 + PQ group. This finding 
is in line with previous study conducted by Hamid et al. 
(2011) on hepatoprotective effects of the same extract. In 
that study, they have shown that 400 mg/kg of Z. zerumbet 
ethyl acetate extract gave a better hepatoprotective effects 
to the paracetamol-induced hepatotoxicity rats compared 
to the 200 mg/kg dosage. 
 Oxidative stress is an imbalance between the 
production of ROS and an antioxidant defense system to 
detoxify the reactive intermediates or to repair the resulting 
damage (Betteridge 2000). Excessive in ROS production 
or impaired antioxidant system will lead to oxidative 
FIGURE 2. Tremor score. Tremor is evaluated based on scoring, the higher the score, the more severe the symptoms 
shown. All animals scored 0 prior to paraquat induction. Based on the graph, there was a decreased in the tremor 
score for both the extract supplemented groups compared to PQ-treated group. Administrations of Z. zerumbet from 
Day 1 - Day 19 (200 mg/kg and 400 mg/kg) alleviated the severity of the tremor during the induction period. Mixed 
ANOVA test revealed significant differences in all groups (p<0.05) during paraquat induction (Day 8-Day 12).
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FIGURE 3. Oxidative stress markers and antioxidant status in the substantia nigra. Paraquat (PQ) induction for 5 consecutive days 
resulted in lower CAT (D) and GPX (E) enzyme activities with a significant increase in the PC level in the SN (B)a. Zingiber zerumbet 
administration reduced the impact of PQ-induced oxidative stress as evidenced by lower levels of MDA (A) and PC (B) in both 200 and 
400 mg/kg groupsc. The reduction in the level of oxidative stress might be contributed by increased activities of antioxidant enzymes; 
SOD (C) CAT (D) and GPx activities (E)c. Data are presented as mean ± SEM with a significant comparison against 
normal control group (p<0.05), bsignificant comparison against positive control group (NAC + PQ)(p<0.05) 
and c significant comparison against PQ-treated group (p<0.05)
imbalance and can cause ROS overproduction. Disruption 
in the normal redox state of cells can cause toxic effects 
through the production of peroxides and free radicals that 
damage all components of the cell, including proteins, 
lipids and DNA (Poljsak et al 2013). 
 In this study, both MDA and the PC levels were 
observed to increase in the PQ-treated group, with only the 
PC level was statistically proven to be significantly higher 
compared to the normal control group. Malondialdehyde 
(MDA) is one of the most frequently used indicator of lipid 
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peroxidation due to its stability. Lipid peroxidation is one 
of the major products of free radical-mediated injury to 
brain because of high concentration of polysaturated fatty 
acid in the brain compared to the other organs (Montine 
et al. 2002). Malfunction of the antioxidant defense 
system causes excessive lipid peroxidation process that 
eventually elevates the level of MDA. The increment in 
the MDA level is considered as an indicator of cellular 
damage (Kaplowitz 2000). 
 Study by Giasson et al. (2002) reported that the 
marker for oxidative stress such as lipid peroxidation 
products was increased in the brains of PD patients. 
Moreover, according to Perfeito et al. (2012), analysis of 
biochemical markers of oxidative damage in brain tissue 
samples and postmortem PD patients showed increased 
levels of MDA and 4-hydroxynonenal in the SN area 
further confirmed the occurrence of lipid peroxidation. 
Due to highly electrophilic properties that can react with 
other biomolecules such as protein and DNA, MDA is 
considered as a highly toxic molecule that can damage 
other molecules and eventually causes cell death (Thanan 
et al 2015). The presence of carbonyl group in proteins 
may indicate that the proteins are exposed to oxidative 
stress damage. Alzheimer’s disease, chronic lung disease, 
chronic renal failure, diabetes and sepsis are examples of 
disorders which are associated with an increase in protein 
carbonyl content in the tissue (Dalle-Donne et al. 2003; 
Kadiiska et al. 2005). 
 In this study, we have proven that administration of 
ethyl acetate extract of Z. zerumbet at both 200 and 400 
mg/kg can reduce the level of MDA and PC compared 
with the PQ-treated group. The ability of these extracts to 
protect the neurons against lipid peroxidation is supported 
by studies from Ruslay et al. (2007). The findings of the 
study reported that ethyl acetate extract of Z. zerumbet able 
to inhibit lipid peroxidation through its radical scavenging 
activities. Previous studies on hepatotoprotective (Hamid 
et al. 2011) and nephroprotective (Abdul Hamid et al. 
2012) also corroborated the findings as both studies 
showed that Z. zerumbet ethyl acetate extract reduced the 
FIGURE 4. Antioxidants status in serum and histopathological observation in substantia nigra. Administrations of PQ for five consecutive 
days caused significant reductions in the serum SOD (A) and CAT (B) activitiesa. In contrast, administration with either 200 or 400 
mg/kg of Z. zerumbet extract significantly increased the activities of these enzymesc. Histological observation of H&E-stained brain 
sections in rats treated with PQ (D) for 5 consecutive days showed the presence of neuronal fragmentations and Lewy bodies in 
the substantia nigra (SN). As for the treatment group, administration of Z. zerumbet extract at the dose of 400 mg/kg showed intact 
nucleus with absence of fragmentations, although the presence of Lewy bodies were still apparent (E). Data are presented as mean 
± SEM with a significant comparison against normal control group (p<0.05), b significant comparison against positive control group 
(NAC + PQ)(p<0.05) and c significant comparison against PQ-treated group (p<0.05)
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level of MDA in both the liver and kidney of chemically-
induced rats. 
 In order to protect our body from the free radical 
toxicity, the production of free radicals are controlled 
by cellular antioxidant defense mechanisms which 
include base-enzymatic and non-enzymatic antioxidants 
(Nordberg & Arner 2001). Antioxidants are substances 
that can prevent or slow the oxidation process. The 
function of antioxidant is to neutralize excess free 
radicals, protecting the cells against the toxic effects 
and for disease prevention (Sailaja Rao et al. 2011). 
Antioxidant enzymes are the first defense systems of cells 
against oxidative damage.
 Activities of CAT and GPx in the SN of the PQ-treated 
group were significantly lower than the normal control 
group (negative control). The main key players that 
provide protection against oxidative stress in the brain 
are SOD, CAT and GPx (Nikolova 2012). Toxins formed in 
the brain are usually removed or deactivated by a variety 
of mechanism of protection. This mechanism however, is 
compromised in Parkinson’s disease when there is a rapid 
drop in the activities of CAT, GPx and GSH concentrations 
in the SN (Ogunro et al. 2014). With the failure of the 
protective mechanism, oxidative stress would easily occur 
and further causes tissue damage (Chinta et al. 2007). In 
addition, the activities of SOD and CAT enzymes in the rat 
serum of PQ-treated group were also lower compared to 
the normal control group. These results were consistent 
with the study conducted by Sanyal et al. (2011), in which 
PD patients have lower antioxidant activity as indicated 
by significantly decreased level of SOD, CAT and GPx 
suggesting that the reduction of these enzymes have a 
correlation with the occurrence of the disease. 
 There were increased in the activities of SOD, 
CAT and GPx enzymes in the group of rats given ethyl 
acetate extract of Z. zerumbet. The increment proves 
that there is an overall enhancement of the endogenous 
antioxidant defense system in the PQ-treated rats. The 
results obtained are in line with study by Hamid et al. 
(2011). In their study, treatment with Z. zerumbet at 200 
and 400 mg/kg were also able to increase the superoxide 
dismutase (SOD) activities in the liver homogenate. The 
antioxidant activities might be attributed to zerumbone, 
the main bioactive compound found in the ethyl acetate 
extract of Z. zerumbet. Zerumbone, a sesquiterpene 
compound and also a potent antioxidant, may indirectly 
induce glutathione biosynthesis and therefore provides 
intracellular protection mechanisms through free radical 
scavenging activity (Ibrahim et al. 2010; Nakamura et al. 
2004). However, the increment was more significantly 
favorable to the 400 mg/kg group compared to 200 mg/kg. 
This may be due to excessive production of free radicals 
following PQ exposure in the SN and the effect of 200 mg/
kg extract of Z. zerumbet was insufficient to overcome 
the detrimental effects of the generated ROS. In all, Z. 
zerumbet proves to have high antioxidant activity through 
induction of endogenous antioxidant that reduces free 
radical activity and this can be evidenced by the results 
of this study. Similarly, this finding is also supported by 
Hamid et al. (2018) that proved the ability of ethyl acetate 
extract of Z. zerumbet in protecting ethanol-induced brain 
damages via its antioxidant property. 
 Substantia nigra (SN) which is located in the midbrain 
plays a role in controlling motor function. The leading 
cause of PD is the loss of dopaminergic neuron in substantia 
nigra pars compacta (Perfeito et al. 2012). Dopaminergic 
neurons are important to ensure normal motor function. 
Based on histological observations of the SN, there was a 
karyolytic feature in the nuclei of neurons in the PQ-treated 
tissues. Karyolysis is one the characteristics of cell death. 
According to Gujral et al. (2002), 99% of cell death is 
characterized by cell lysis, vacuole formation, karyolysis 
and karryorhexis (Gujral et al. 2002). Cell death can be 
due to apoptosis or necrosis. This is supported by research 
done by Somayajulu-Nitu (2009), which showed that PQ at 
the dose of 10 mg/kg/week for 3 weeks had resulted in the 
death of 65% dopaminergic neurons in the SN. Similarly, 
a study conducted by Shimizu et al. (2003) showed that 
subchronic administration of PQ at the dose of 10 mg/kg 
for 5 days was capable of causing death to dopaminergic 
neurons. 
 Histological features for ethyl acetate extract of Z. 
zerumbet at the dose of 400 mg/kg showed that there was 
no fragmentation detected in the nucleus of the neurons. 
This indicates that ethyl acetate extract of Z. zerumbet 
at this particular dose may prevent neuronal cell death 
from occurring. Besides that, the histological hallmark 
of Parkinson’s disease (PD) is the presence of fibrillar 
aggregates called Lewy bodies (LBs). Formation of LBs is 
considered to be the indicator for neuronal degeneration 
because the neuronal loss is found in the predilection sites 
for LBs (Wakabayashi et al. 2007). 
CONCLUSION
Based on the results obtained, it can be concluded 
that administration of the ethyl acetate extract of Z. 
zerumbet provides neuroprotective effect on PQ-induced 
Parkinsonism in rats. The inhibition of oxidative stress 
was evidenced by reduction of lipid and proteins oxidation 
and enhanced antioxidant enzyme activities (SOD, CAT and 
GPx). The most significant effect was observed with the 
administration of 400 mg/kg of extract compared to a lower 
dose of 200 mg/kg. This finding indicates the difference in 
the presence and amount of antioxidant compounds that 
contribute significantly to Zingiber zerumbet antioxidant 
property. 
 Ethyl acetate extract of Z. zerumbet at the dosage of 
200 mg/kg and 400 mg/kg have been found to prevent 
oxidative stress and neuronal damage induced by 
paraquat and therefore, can be developed as a preventive 
and therapeutic agent for neurodegenerative-induced 
environmental toxins. The authors have declared no 
conflict of interest. 
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